Valion Bio regains Nasdaq minimum bid compliance; Nasdaq matter closed
Nasdaq notified Valion Bio that it has regained compliance with the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2), and the matter is closed.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.